- Home
- KALA vs PYN Comparison
KALA vs PYN Comparison
Compare KALA & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- PYN
- Stock Information
- Founded
- KALA 2009
- PYN 2002
- Country
- KALA United States
- PYN United States
- Employees
- KALA N/A
- PYN N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- PYN Investment Managers
- Sector
- KALA Health Care
- PYN Finance
- Exchange
- KALA Nasdaq
- PYN Nasdaq
- Market Cap
- KALA 26.2M
- PYN 30.1M
- IPO Year
- KALA 2017
- PYN N/A
- Fundamental
- Price
- KALA $5.16
- PYN $5.31
- Analyst Decision
- KALA Strong Buy
- PYN
- Analyst Count
- KALA 3
- PYN 0
- Target Price
- KALA $14.00
- PYN N/A
- AVG Volume (30 Days)
- KALA 71.9K
- PYN 19.9K
- Earning Date
- KALA 08-05-2025
- PYN 01-01-0001
- Dividend Yield
- KALA N/A
- PYN 5.07%
- EPS Growth
- KALA N/A
- PYN N/A
- EPS
- KALA N/A
- PYN N/A
- Revenue
- KALA N/A
- PYN N/A
- Revenue This Year
- KALA N/A
- PYN N/A
- Revenue Next Year
- KALA N/A
- PYN N/A
- P/E Ratio
- KALA N/A
- PYN N/A
- Revenue Growth
- KALA N/A
- PYN N/A
- 52 Week Low
- KALA $2.92
- PYN $4.84
- 52 Week High
- KALA $11.20
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- KALA 61.92
- PYN 54.64
- Support Level
- KALA $4.36
- PYN $5.20
- Resistance Level
- KALA $5.75
- PYN $5.30
- Average True Range (ATR)
- KALA 0.53
- PYN 0.11
- MACD
- KALA 0.07
- PYN 0.01
- Stochastic Oscillator
- KALA 64.39
- PYN 11.29
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.